Home » Topics » Regulatory

Regulatory
RSS

FDA approves new epilepsy treatment

Dec. 2, 1999

V1A/AT1 receptor antagonist combinations for cardiovascular disorders

Dec. 2, 1999

Combinations of imidazoles for female genital infections

Dec. 1, 1999

NMDA antagonists reported to be useful for IBS

Dec. 1, 1999

Team from P&G discovers new use for an old drug

Dec. 1, 1999

New Zomig formulation receives European regulatory approval

Nov. 25, 1999

U.S. academic team takes a novel approach to treating prostate cancer

Nov. 24, 1999

Patent for paclitaxel formulations issued to NaPro BioTherapeutics

Nov. 23, 1999

Launch imminent for Fujisawa's new treatment of atopic dermatitis

Nov. 22, 1999

BMS seeks approval in U.S. for Glucophage XR tablets

Nov. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...